Background: Over the past several decades, there has been a rapid worldwide increase in
the prevalence of papillary thyroid cancer (PTC) as well as a number of changes in the …

Background. The BRAF V600E mutation is an important genetic event in papillary thyroid
cancer (PTC). This study aimed to provide additional information regarding the association …

Recent studies have demonstrated that BRAFV600E mutation is a common event in
papillary thyroid carcinoma and a majority of these lesions have shown a direct relationship …

OBJECTIVES: In recent years, BRAFV600E mutation has emerged as a promising
prognostic marker for risk stratification of patients with papillary thyroid carcinoma (PTC) …

The BRAFV600E mutation is commonly found in papillary thyroid cancers (PTCs) at different
frequencies in different regions. However, the association between the BRAFV600E …

Abstract Background The BRAF V600E mutation is the most common genetic alteration
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …

Objective Papillary thyroid carcinoma (PTC) accounts for 95% of all thyroid carcinomas. PTC
is an epithelial tumor characterized by the proliferation of follicular cells with distinctive …

Objective Genetic alterations in four oncogenes, namely RAS point mutations, RET
rearrangements (RET/PTC), NTRK1 rearrangements (TRK) and BRAF point mutations have …

Background: The BRAFV600E mutation is the most frequent genetic alteration in papillary
thyroid carcinoma (PTC). The role of BRAFV600E mutation as a poor prognostic factor has …

Background Activating somatic mutation of the BRAF V600E has been identified as the most
common genetic event in papillary thyroid carcinoma (PTC) with a variable frequency (32 …